Etiology and prognosis of acute respiratory failure in patients with primary malignant brain tumors admitted to the intensive care unit.


Journal

Journal of neuro-oncology
ISSN: 1573-7373
Titre abrégé: J Neurooncol
Pays: United States
ID NLM: 8309335

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 08 10 2018
accepted: 05 12 2018
pubmed: 12 12 2018
medline: 22 6 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

Acute respiratory failure (ARF) is common and potentially fatal in patients with primary malignant brain tumors (PMBT). However, few data are available regarding its precipitating factors and prognosis. We sought to: (1) compare the causes of ARF and the outcome between patients with PMBT and patients with other peripheral solid tumors (PST), (2) identify the factors influencing ICU survival in PMBT patients. Two-center retrospective case-control study from March 1996 to May 2014. Primary central nervous system lymphomas were also included. Eighty-four patients with PMBT and 133 patients with PST were included. Acute infectious pneumonia was more frequent in PMBT than PST patients (77 vs. 36%, p < 0.001). Pulmonary embolism was also more frequent in PMBT patients (13% vs. 5%, p = 0.042), while cardiogenic pulmonary edema and acute-on-chronic respiratory failure were more frequent in PST patients (37 vs. 10%, p < 0.001). Among acute infectious pneumonia, Pneumocystis pneumonia and aspiration pneumonia were more frequent in PMBT patients (19 vs. 2%, p < 0.001 and 19 vs. 8%, p < 0.001, respectively). ICU mortality was similar between PMBT and PST patients (24% vs. 24%, p = 0.966). In multivariate analysis, cancer progression (OR 7.25 95% CI 1.13-46.45, p = 0.034), need for intubation (OR 7.01 95% CI 1.29-38.54, p = 0.022), were independently associated with ICU mortality in PMBT patients. The cause of ARF in patients with PMBT differs significantly than those with PST and up to 50% may have been prevented. Mortality did not differ between the two groups. These results suggest that PMBT alone is not a relevant criterion for ICU recusal.

Identifiants

pubmed: 30536197
doi: 10.1007/s11060-018-03074-y
pii: 10.1007/s11060-018-03074-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

139-148

Références

Surg Neurol. 2000 May;53(5):432-7; discussion 437-8
pubmed: 10874141
Neuro Oncol. 2002 Oct;4(4):278-99
pubmed: 12356358
Gastroenterol Clin North Am. 2003 Jun;32(2):553-75
pubmed: 12858606
J Neurooncol. 2003 Jul;63(3):263-70
pubmed: 12892232
Dysphagia. 2003 Summer;18(3):203-10
pubmed: 14506986
Medicine (Baltimore). 2004 Nov;83(6):360-70
pubmed: 15525848
Crit Care Med. 2004 Nov;32(11 Suppl):S578-90
pubmed: 15542967
Lancet. 2005 Feb 26-Mar 4;365(9461):764-72
pubmed: 15733717
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1423-6
pubmed: 16029802
Intensive Care Med. 2006 Jun;32(6):808-22
pubmed: 16715324
J Neurosurg. 2007 Apr;106(4):601-8
pubmed: 17432710
Mayo Clin Proc. 2007 Sep;82(9):1052-9
pubmed: 17803871
JAMA. 2008 Nov 19;300(19):2277-85
pubmed: 19017914
Lancet. 2009 Oct 31;374(9700):1512-20
pubmed: 19767089
Arch Neurol. 1991 Apr;48(4):406-9
pubmed: 2012515
Medicine (Baltimore). 2010 Sep;89(5):308-18
pubmed: 20827108
Neurology. 2010 Nov 23;75(21):1912-9
pubmed: 21098406
J Neurooncol. 2011 Aug;104(1):225-31
pubmed: 21104297
Clin Dev Immunol. 2012;2012:831090
pubmed: 23133490
Leuk Lymphoma. 2013 Aug;54(8):1724-9
pubmed: 23185988
World Neurosurg. 2014 Nov;82(5):822-7
pubmed: 23318935
Ann Intern Med. 1990 May 1;112(9):716
pubmed: 2334088
J Clin Oncol. 2013 Aug 1;31(22):2810-8
pubmed: 23752112
Ann Rehabil Med. 2013 Oct;37(5):633-41
pubmed: 24231855
Ann Oncol. 2014 Sep;25 Suppl 3:iii93-101
pubmed: 24782454
Intensive Care Med. 2014 Aug;40(8):1106-14
pubmed: 24898895
Thromb Res. 2015 Mar;135(3):472-8
pubmed: 25547213
J Clin Oncol. 2015 Feb 20;33(6):654-6
pubmed: 25605844
Lancet Oncol. 2015 Jul;16(7):e322-32
pubmed: 26149884
J Neurooncol. 2016 Mar;127(1):111-7
pubmed: 26608523
J Neurooncol. 2016 Mar;127(1):73-81
pubmed: 26619998
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
J Neurol. 2017 Nov;264(11):2303-2312
pubmed: 28993874
J Neurooncol. 2018 Jan;136(2):403-411
pubmed: 29143923
Am J Clin Oncol. 1982 Dec;5(6):649-55
pubmed: 7165009
J Clin Epidemiol. 1994 Nov;47(11):1245-51
pubmed: 7722560
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
Mayo Clin Proc. 1996 Jan;71(1):5-13
pubmed: 8538233
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
J Neurooncol. 1996 Mar;27(3):235-40
pubmed: 8847557

Auteurs

Maxens Decavèle (M)

Sorbonne Universités, UPMC Univ Paris 06, INSERM, UMRS_1158 Neurophysiologie respiratoire expérimentale et clinique, Paris, France. maxencesar@hotmail.fr.
AP-HP, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Service de Pneumologie et Réanimation Médicale (Département "R3S"), F-75013, Paris, France. maxencesar@hotmail.fr.

Isabelle Rivals (I)

Sorbonne Universités, UPMC Univ Paris 06, INSERM, UMRS_1158 Neurophysiologie respiratoire expérimentale et clinique, Paris, France.
Equipe de Statistique Appliquée, ESPCI Paris, PSL Research University, UMRS 1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, France.

Clémence Marois (C)

AP-HP, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Service de Pneumologie et Réanimation Médicale (Département "R3S"), F-75013, Paris, France.

Marie Cantier (M)

AP-HP, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Service de Pneumologie et Réanimation Médicale (Département "R3S"), F-75013, Paris, France.

Nicolas Weiss (N)

Sorbonne Université, Brain Liver Pitié-Salpêtrière (BLIPS) Study Group, INSERM UMR_S 938, Centre de Recherche Saint-Antoine, Assistance Publique - Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière Charles Foix, Département de Neurologie, Unité de réanimation neurologique, Paris, France.

Léa Lemasle (L)

AP-HP, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Service de Pneumologie et Réanimation Médicale (Département "R3S"), F-75013, Paris, France.

Hélène Prodanovic (H)

AP-HP, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Service de Pneumologie et Réanimation Médicale (Département "R3S"), F-75013, Paris, France.

Khe Hoang-Xuan (K)

Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, 75013, Paris, France.

Ahmed Idbaih (A)

Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, 75013, Paris, France.

Thomas Similowski (T)

Sorbonne Universités, UPMC Univ Paris 06, INSERM, UMRS_1158 Neurophysiologie respiratoire expérimentale et clinique, Paris, France.
AP-HP, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Service de Pneumologie et Réanimation Médicale (Département "R3S"), F-75013, Paris, France.

Alexandre Demoule (A)

Sorbonne Universités, UPMC Univ Paris 06, INSERM, UMRS_1158 Neurophysiologie respiratoire expérimentale et clinique, Paris, France.
AP-HP, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Service de Pneumologie et Réanimation Médicale (Département "R3S"), F-75013, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH